Search Results

Pralatrexate 5mg 5mg  | Purity Not Available

Adooq Bioscience

Pralatrexate is an antifolate (a folate analogue metabolic inhibitor) designed to accumulate preferentially in cancer cells.

More Information Supplier Page

Pralatrexate 25mg 25mg  | Purity Not Available

Adooq Bioscience

Pralatrexate is an antifolate (a folate analogue metabolic inhibitor) designed to accumulate preferentially in cancer cells.

More Information Supplier Page

PSI-7977 10mg 10mg  | Purity Not Available

Adooq Bioscience

PSI-7977 is a phosphoramidate prodrug of PSI-7851, a nucleoside analog that, when phosphorylated, inhibits the RNA-dependent RNA polymerase of hepatitis C virus (EC50 = 92 nM).

More Information Supplier Page

Paricalcitol 2mg 2mg  | Purity Not Available

Adooq Bioscience

Paricalcitol is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.

More Information Supplier Page

Paricalcitol 1mg 1mg  | Purity Not Available

Adooq Bioscience

Paricalcitol is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.

More Information Supplier Page

PSI-6206 50mg 50mg  | Purity Not Available

Adooq Bioscience

PSI-6206 is the deaminated derivative of PSI-6130, which is a potent inhibitor of hepatitis C virus (HCV) replication in the subgenomic HCV reolicon system.

More Information Supplier Page

PSI-6206 5mg 5mg  | Purity Not Available

Adooq Bioscience

PSI-6206 is the deaminated derivative of PSI-6130, which is a potent inhibitor of hepatitis C virus (HCV) replication in the subgenomic HCV reolicon system.

More Information Supplier Page

PSI-6206 25mg 25mg  | Purity Not Available

Adooq Bioscience

PSI-6206 is the deaminated derivative of PSI-6130, which is a potent inhibitor of hepatitis C virus (HCV) replication in the subgenomic HCV reolicon system.

More Information Supplier Page